Omnicare
USAWho owns Omnicare?
Omnicare is an American Pharma company, now owned by Allianz ambulante Onkologie, which acquired it in 2026 from Equistone Partners Europe.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Fully exited in 2026 to Allianz ambulante Onkologie.
- ·Average hold across 2 realized cycles: 7 years.
Ownership history
2 ownership periods · co-invest detected
Equistone Partners Europe sold Omnicare to Allianz ambulante Onkologie in 2026 after 7 years.
Equistone Partners sold Omnicare to Allianz ambulante Onkologie in 2026 after 7 years.
More from Equistone Partners Europe Fund VI
Other portfolio companies in the same fund.
UK
Netherlands
Germany
Switzerland
More PE-backed in Pharma
Comparable pharma deals from other GPs.
France
SpainQuestions
Who owns Omnicare?
Omnicare is now owned by Allianz ambulante Onkologie, which acquired it in 2026 from Equistone Partners Europe.
When did Allianz ambulante Onkologie acquire Omnicare?
Allianz ambulante Onkologie acquired Omnicare in 2026, buying from Equistone Partners Europe.
Who did Omnicare sell to?
Equistone Partners Europe and Equistone Partners sold Omnicare to Allianz ambulante Onkologie in 2026 (Trade Sale).
Who has owned Omnicare over time?
Omnicare has been through 2 private-equity ownership periods: Equistone Partners Europe · via Equistone Partners Europe Fund VI · 2019–2026 · sold to Allianz ambulante Onkologie · (Trade Sale); Equistone Partners · via Equistone Fund VI · 2019–2026 · sold to Allianz ambulante Onkologie · (MBO).